Nanosonics delays product launch due to pandemic
Key Points
- Revenue ($m) 100.1, up 18.7%
- Pre-tax profit ($m) 12.4, down 26.2%
- Net profit ($m) 10.1, down 25.7%
- Final dividend (c) nil vs nil
Infection prevention medical device company Nanosonics has pushed back the launch date of its much-anticipated second product to 2022, as the business continues to grapple with the consequences of COVID-19.
On Tuesday the business revealed that fourth-quarter sales of its microwave-sized device called Trophon, which sterilises ultrasound probes without chemicals, had plummeted, as its sales representatives struggled to get access to hospitals in the US amid the pandemic.
Subscribe to gift this article
Gift 5 articles to anyone you choose each month when you subscribe.
Subscribe nowAlready a subscriber?
Introducing your Newsfeed
Follow the topics, people and companies that matter to you.
Find out moreRead More
Latest In Healthcare & fitness
Fetching latest articles